For decades, tuberculosis was the disease India measured in millions and mourned in hundreds of thousands. New WHO estimates suggest the country can now measure it differently: an estimated 18 TB deaths per lakh population in 2025, down from 28 per lakh in 2015.
That is a 38% decline in a decade. Alongside it, the treatment success rate — the share of patients who complete care and are declared cured — now stands at 94%.
Two numbers, and what they actually measure
The first number is mortality: deaths per 100,000 people, estimated rather than counted, because not every TB death in India is formally recorded as one. The second is treatment success, calculated among patients registered for care whose outcomes are known.
Read together, they describe a system that is both losing fewer patients and holding on to more of the ones it treats. That combination is rarer than it sounds in high-burden countries.
Why a slower death rate changes more than a statistic
TB is an airborne bacterial infection that most often attacks the lungs, and in India it has historically been entangled with poverty, malnutrition and crowded housing. A death from TB is usually preceded by weeks of lost wages — for the patient and often for the person who stops working to care for them.
So a fall in the mortality rate is not an abstract ledger entry. It translates into households that keep an earning member, children who stay in school, and fewer families pushed into debt by a curable disease.
How India reached this point
The improvement did not arrive in one step. Over the past decade, India's National TB Elimination Programme expanded free diagnosis and free drugs, made TB notification mandatory for private doctors, ran mass case-finding drives, and began transferring monthly nutrition support directly into patients' bank accounts.
Each measure addressed a different leak in the pipeline — the patient who never got tested, the one who tested positive but went to a private clinic and was never counted, and the one who started treatment but stopped when the symptoms eased and the food money ran out.
Who is actually better off — and who may not be
The gains are real, but they are not evenly distributed. Men, working-age adults, and people in states with weaker health infrastructure continue to carry a disproportionate share of cases. Undernourished patients and those with diabetes face longer, harder treatment courses.
For a patient today, the practical meaning of these numbers is simpler than the epidemiology: the odds of being diagnosed, treated and cured in India are better than they were a decade ago, and the odds of dying are materially lower.
What WHO's estimates do and do not claim
India does not count every TB case and every TB death; no large country does. WHO's figures are modelled estimates that draw on notification data, surveys, and assumptions about the share of cases the system never sees.
That makes them the most reliable comparable picture available — and also the reason health economists treat year-on-year movements cautiously, while treating a decade-long trend as meaningful.
The gap between 28-to-18 and 38%
A fall from 28 to 18 per lakh works out to roughly a 36% reduction. The headline figure of 38% is slightly larger, which could reflect rounding on a more granular estimate, a fractional base rate, or a different calculation method.
The available information does not specify which. It also does not give absolute death counts, so the per-lakh rate cannot be converted into a national total without population denominators.
Confirmed Facts vs What Remains Unclear
Confirmed: WHO estimates place India's TB mortality rate at 18 per lakh population in 2025, against 28 per lakh in 2015, with a reported 38% decline and a 94% treatment success rate.
Unclear: The exact baseline and methodology behind the 38% figure, the absolute number of TB deaths involved, whether the mortality estimate is for a calendar year or a reporting period, and whether state-level breakdowns are available.
Not claimed: That India has eliminated TB, or that the disease is no longer a public health emergency. Both would be false.
The risks that could stall the decline
Drug-resistant TB remains the most serious threat. It requires longer, more expensive regimens, has lower cure rates, and can undo progress if diagnosis is delayed.
Two other weaknesses persist: cases that never reach the formal system, particularly in the private sector, and patients who interrupt treatment after feeling better. Both inflate transmission quietly, and neither shows up cleanly in success-rate statistics, which count only those already registered.
A decade-long shift, not an Indian exception
Globally, TB deaths have been falling more slowly than case numbers, and the COVID-19 years reversed progress in several countries by disrupting diagnosis and treatment. India's trajectory runs against that disruption — which is why the numbers are being read as a sign of programme resilience rather than a single good year.
What this means for patients and families right now
A cough lasting more than two weeks, evening fever, night sweats, unexplained weight loss or blood in the sputum should prompt a test. TB testing and treatment are free in the public system, and notification by private practitioners is mandatory.
For anyone already on treatment, the 94% success figure carries a condition: it is built on patients who finish the full course. Stopping early is the single most common way a curable infection becomes a dangerous one.
What to watch next
Three indicators will show whether the decline holds — the proportion of drug-resistant cases detected and cured, the share of patients diagnosed in the private sector, and whether mortality keeps falling among the poorest and most undernourished groups rather than only in better-served districts.
Our Take
A 38% fall in TB mortality is the kind of progress that rarely produces a headline, because it arrives slowly and lacks a single dramatic moment. It is nonetheless one of the more consequential public health shifts in India in the past decade.
The honest reading is that the programme has become better at finding and holding on to patients, while the hardest problems — resistance, missed cases, and the poverty that feeds the disease — remain unsolved. Progress on a disease like TB is never a finish line; it is a lead that has to be defended every year.
Frequently Asked Questions
How much has India's TB mortality rate fallen?
According to WHO estimates, India's TB mortality rate fell from 28 per lakh population in 2015 to 18 per lakh in 2025 — a decline of 38%.
What does a 94% TB treatment success rate mean?
It means that among TB patients registered for treatment and whose outcomes are known, 94% completed their course and were declared cured or treatment-completed. It does not include patients who were never diagnosed or never entered the system.
Is India close to eliminating TB?
No. Elimination means near-zero new cases, and India still carries the world's largest TB burden. The current figures show substantial progress in reducing deaths and improving cure rates, not the end of the epidemic.
Why are WHO's numbers called "estimates"?
Because not every TB case and death is formally recorded. WHO models the total using notification data, prevalence surveys and assumptions about undetected cases, which is why the figures are treated as estimates rather than exact counts.
Where can a suspected TB patient get tested in India?
At government health centres and designated microscopy or molecular testing centres under the National TB Elimination Programme, where diagnosis and treatment are provided free of cost.